Inventor · disambiguated record
Steven Mark Dunn
Also filed as: DUNN STEVEN · DUNN STEVEN M · DUNN STEVEN MARK · MOLLOY PETER EAMON
14 granted patents·4 pending applications·133 citations·filing 1996–2020
92Inventor score
Files withIMMUNOCORE LTD5ADAPTIMMUNE LTD4LUDWIG INST FOR CANCER RES LTD3BOULTER JONATHAN MICHAEL2ADAPTIMMUE LTD1
Top patents by PatentIndex Score
18 records- 0195US8367804B2High affinity NY-ESO T cell receptorsIMMUNOCORE LTD·Filed 2011·Granted Feb 5, 2013·20 cites·4 claims
- 0294US8008438B2High affinity NY-ESO T cell receptorsIMMUNOCORE LTD·Filed 2010·Granted Aug 30, 2011·11 cites·2 claims
- 0394US7608410B2Method of improving T cell receptorsIMMUNOCORE LTD·Filed 2008·Granted Oct 27, 2009·51 cites·13 claims
- 0491US11657912B2Devices, systems, and their methods of use for evaluating and processing remuneration claims from third-party obligatorPARADIGM SENIOR SERVICES INC·Filed 2020·Granted May 23, 2023·8 cites·20 claims
- 0590US9822163B2High affinity NY-ESO T cell receptorsADAPTIMMUNE LTD·Filed 2016·Granted Nov 21, 2017·3 cites·4 claims
- 0690US8143376B2High affinity NY-ESO T cell receptorBOULTER JONATHAN MICHAEL·Filed 2005·Granted Mar 27, 2012·17 cites·69 claims
- 0788US9255135B2High affinity HIV T cell receptorsIMMUNOCORE LTD·Filed 2013·Granted Feb 9, 2016·5 cites·19 claims
- 0887US9512197B2High affinity NY-ESO T cell receptorsADAPTIMMUNE LTD·Filed 2015·Granted Dec 6, 2016·2 cites·3 claims
- 0987US8378074B2High affinity HIV T cell receptorsIMMUNOCORE LTD·Filed 2006·Granted Feb 19, 2013·9 cites·24 claims
- 1075US2021061878A1High affinity ny-eso t cell receptorsADAPTIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1169US2018371049A1High affinity ny-eso t cell receptorsADAPTIMMUE LTD·Filed 2018·Application pending·0 cites
- 1266US9156903B2High affinity NY-ESO T cell receptorsBOULTER JONATHAN MICHAEL·Filed 2012·Granted Oct 13, 2015·0 cites·9 claims
- 1366US2018072788A1High affinity ny-eso t cell receptorsADAPTIMMUNE LTD·Filed 2017·Application pending·0 cites
- 1456US12503504B2Humanized and variant TGF-β1 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2019·Granted Dec 23, 2025·0 cites·28 claims
- 1551US2021388074A1Humanized and variant tgf-beta3 specific antibodies and methods and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2019·Application pending·0 cites
- 1646USD393371SHanger separatorDUNN STEVEN M·Filed 1996·Granted Apr 14, 1998·7 cites·1 claims
- 1745US12297276B2Anti-TEM1 antibodies and antigen-binding portions thereofLUDWIG INST FOR CANCER RES LTD·Filed 2020·Granted May 13, 2025·0 cites·32 claims
- 1826US10364296B2Antibodies specific for MMP9CALYPSO BIOTECH SA·Filed 2015·Granted Jul 30, 2019·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Steven Mark Dunn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →